T. Rowe Price Investment Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-185,550	Closed	-$33.5M	–	714
2025 Q1	$33.5M	Buy	+185,550	New	+$33.5M	0.02%	450